What factors should be considered when deciding whether to omit radiation in pediatric/AYA patients receiving N+AVD, particularly regarding long-term outcomes and second malignancy risks?
Community PollStarted
Is the SWOG 1826 data strong enough for you to omit radiation in pediatric/AYA patients?
41 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet Member
Pediatric Hematology/Oncology · Aflac Cancer and Blood Disorders Center/ Children's Healthcare of Atlanta - Egleston
Answered on
Based on the early data from S1826, it appears that radiation can be omitted if end-of-therapy scans (after 6 cycles of therapy) show metabolic remission of disease. The ability to limit RT to 1% of patients is encouraging for potential reduction in late effects such as cardiovascular disease and SM...
Join for free or sign in to see the full answer